매출 흑자인데 영업CF 적자 (OCF/매출 -35%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Retractable Technologies financial statements
리트랙터블 테크놀로지스NYSEAMERICAN:RVP · NYSE Amex · Healthcare · sector #17Retractable Technologies's published financial data is dated 2026-10-04. 2024 revenue was $33M. 2024 operating profit was −$21M.
Reported results
Financial safety
Reference indicatorAs of 2024- Altman Z''
- 3.54
- Beneish M-Score
- -2.81
- Sloan accrual
- -0.20%
No statistical flag
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
Piotroski measures year-over-year financial improvement, not absolute quality.
Profitability
- Positive ROANot passed
- Positive OCFNot passed
- Improving ΔROANot passed
- Accruals (OCF > net income)Pass
Leverage & liquidity
- Lower debtNot passed
- Higher current ratioPass
- No new sharesPass
Efficiency
- Higher gross marginNot passed
- Higher asset turnoverNot passed
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
현금전환주기(CCC) 3기 연속 확대 — 운전자본 경색·현금 회수 지연 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
영업이익률 악화 (-26.4% → -63.9%, -37.5%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- -63.9%
- Interest coverage
- -172.3x
- Return on equity (ROE)
- -13.6%
Operating margin −5pp
Operating lossRevenue −15%
Interest coverage riskInterest rate +2pp
Interest coverage riskInterest coverage limit
Already below the limit by 64.2ppInterest coverage limit at an operating margin of 0.4%
Interest expense coverage threshold